Published in Am J Hum Genet on June 26, 2007
Gene--environment-wide association studies: emerging approaches. Nat Rev Genet (2010) 6.10
Prioritizing GWAS results: A review of statistical methods and recommendations for their application. Am J Hum Genet (2010) 5.39
Network-based global inference of human disease genes. Mol Syst Biol (2008) 5.01
A powerful and flexible multilocus association test for quantitative traits. Am J Hum Genet (2008) 4.96
An open access database of genome-wide association results. BMC Med Genet (2009) 4.61
Interpreting noncoding genetic variation in complex traits and human disease. Nat Biotechnol (2012) 3.01
Joint analysis of functional genomic data and genome-wide association studies of 18 human traits. Am J Hum Genet (2014) 2.55
Prostate cancer genomics: towards a new understanding. Nat Rev Genet (2008) 2.08
Methods for investigating gene-environment interactions in candidate pathway and genome-wide association studies. Annu Rev Public Health (2010) 1.88
Systematic biological prioritization after a genome-wide association study: an application to nicotine dependence. Bioinformatics (2008) 1.85
Genome-wide association studies and beyond. Annu Rev Public Health (2010) 1.73
Identifying causal variants at loci with multiple signals of association. Genetics (2014) 1.41
A unified mixed-effects model for rare-variant association in sequencing studies. Genet Epidemiol (2013) 1.29
Use of pathway information in molecular epidemiology. Hum Genomics (2009) 1.22
Analyzing 'omics data using hierarchical models. Nat Biotechnol (2010) 1.21
Integrated enrichment analysis of variants and pathways in genome-wide association studies indicates central role for IL-2 signaling genes in type 1 diabetes, and cytokine signaling genes in Crohn's disease. PLoS Genet (2013) 1.14
Genetic polymorphism and prostate cancer aggressiveness: a case-only study of 1,536 GWAS and candidate SNPs in African-Americans and European-Americans. Prostate (2012) 1.14
Gains in power for exhaustive analyses of haplotypes using variable-sized sliding window strategy: a comparison of association-mapping strategies. Eur J Hum Genet (2008) 1.13
Were genome-wide linkage studies a waste of time? Exploiting candidate regions within genome-wide association studies. Genet Epidemiol (2010) 1.12
Complex diseases, complex genes: keeping pathways on the right track. Epidemiology (2009) 1.10
Inclusion of a priori information in genome-wide association analysis. Genet Epidemiol (2009) 1.06
Methodological Issues in Multistage Genome-wide Association Studies. Stat Sci (2009) 1.06
An efficient hierarchical generalized linear mixed model for pathway analysis of genome-wide association studies. Bioinformatics (2011) 1.01
Recommendations and proposed guidelines for assessing the cumulative evidence on joint effects of genes and environments on cancer occurrence in humans. Int J Epidemiol (2012) 0.99
Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls. Hum Genet (2013) 0.93
Bayesian mixture models for the incorporation of prior knowledge to inform genetic association studies. Genet Epidemiol (2010) 0.92
Improved detection of rare genetic variants for diseases. PLoS One (2010) 0.91
Integration of gene ontology pathways with North American Rheumatoid Arthritis Consortium genome-wide association data via linear modeling. BMC Proc (2009) 0.88
Using linkage analysis to identify quantitative trait loci for sleep apnea in relationship to body mass index. Ann Hum Genet (2008) 0.88
SNP prioritization using a Bayesian probability of association. Genet Epidemiol (2012) 0.86
A latent model for prioritization of SNPs for functional studies. PLoS One (2011) 0.86
A Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal Cancer. Cancer Epidemiol Biomarkers Prev (2015) 0.85
Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer. J Natl Cancer Inst (2015) 0.85
Joint association testing of common and rare genetic variants using hierarchical modeling. Genet Epidemiol (2012) 0.84
Replication of breast cancer susceptibility loci in whites and African Americans using a Bayesian approach. Am J Epidemiol (2013) 0.84
Two novel pathway analysis methods based on a hierarchical model. Bioinformatics (2013) 0.84
Analysis of exome sequences with and without incorporating prior biological knowledge. Genet Epidemiol (2011) 0.84
Predicting functionally important SNP classes based on negative selection. BMC Bioinformatics (2011) 0.82
Two-phase and family-based designs for next-generation sequencing studies. Front Genet (2013) 0.82
Invited commentary: more surprises from a gene desert. Am J Epidemiol (2012) 0.80
Two-stage design of sequencing studies for testing association with rare variants. Hum Hered (2011) 0.80
Leveraging Multi-ethnic Evidence for Mapping Complex Traits in Minority Populations: An Empirical Bayes Approach. Am J Hum Genet (2015) 0.79
Hierarchical regression for multiple comparisons in a case-control study of occupational risks for lung cancer. PLoS One (2012) 0.77
Joint analysis for integrating two related studies of different data types and different study designs using hierarchical modeling approaches. Hum Hered (2013) 0.77
Identification of lung cancer histology-specific variants applying Bayesian framework variant prioritization approaches within the TRICL and ILCCO consortia. Carcinogenesis (2015) 0.75
Using local multiplicity to improve effect estimation from a hypothesis-generating pharmacogenetics study. Pharmacogenomics J (2015) 0.75
Presenting the uncertainties of odds ratios using empirical-Bayes prediction intervals. PLoS One (2012) 0.75
The performance of a new local false discovery rate method on tests of association between coronary artery disease (CAD) and genome-wide genetic variants. PLoS One (2017) 0.75
Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23
The International HapMap Project. Nature (2003) 73.65
Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res (2005) 44.08
Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet (1998) 40.97
The ENCODE (ENCyclopedia Of DNA Elements) Project. Science (2004) 38.24
Genetic analysis of genome-wide variation in human gene expression. Nature (2004) 27.28
Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst (2004) 19.00
Mapping determinants of human gene expression by regional and genome-wide association. Nature (2005) 17.24
Evaluating and improving power in whole-genome association studies using fixed marker sets. Nat Genet (2006) 14.76
Using linkage genome scans to improve power of association in genome scans. Am J Hum Genet (2006) 5.67
Two-stage designs for gene-disease association studies. Biometrics (2002) 3.67
Stratified false discovery control for large-scale hypothesis testing with application to genome-wide association studies. Genet Epidemiol (2006) 2.45
Hierarchical modeling of linkage disequilibrium: genetic structure and spatial relations. Am J Hum Genet (2003) 2.05
Methods for epidemiologic analyses of multiple exposures: a review and comparative study of maximum-likelihood, preliminary-testing, and empirical-Bayes regression. Stat Med (1993) 1.88
Using hierarchical modeling in genetic association studies with multiple markers: application to a case-control study of bladder cancer. Cancer Epidemiol Biomarkers Prev (2004) 1.72
Hierarchical regression analysis applied to a study of multiple dietary exposures and breast cancer. Epidemiology (1994) 1.71
Empirical-Bayes and semi-Bayes approaches to occupational and environmental hazard surveillance. Arch Environ Health (1994) 1.60
A semi-Bayes approach to the analysis of correlated multiple associations, with an application to an occupational cancer-mortality study. Stat Med (1992) 1.48
The functional importance of disease-associated mutation. BMC Bioinformatics (2002) 1.41
Simulation study of hierarchical regression. Stat Med (1996) 1.39
Genetic analysis with hierarchical models. Genet Epidemiol (1997) 1.28
Dissecting effects of complex mixtures: who's afraid of informative priors? Epidemiology (2007) 1.21
Empirical Bayes methods for testing associations with large numbers of candidate genes in the presence of environmental risk factors, with applications to HLA associations in IDDM. Ann Med (1992) 1.02
Second-stage least squares versus penalized quasi-likelihood for fitting hierarchical models in epidemiologic analyses. Stat Med (1997) 0.96
Hierarchical modeling of the relation between sequence variants and a quantitative trait: addressing multiple comparison and population stratification issues. Genet Epidemiol (2001) 0.90
Hierarchical modeling in association studies of multiple phenotypes. BMC Genet (2005) 0.89
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Point: population stratification: a problem for case-control studies of candidate-gene associations? Cancer Epidemiol Biomarkers Prev (2002) 6.00
RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat Genet (2002) 3.87
Genetic dissection of complex traits with chromosome substitution strains of mice. Science (2004) 3.57
The landscape of recombination in African Americans. Nature (2011) 3.06
Comprehensive approach to analyzing rare genetic variants. PLoS One (2010) 2.93
The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med (2009) 2.91
Multiple prostate cancer risk variants on 8q24. Nat Genet (2007) 2.76
Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat Genet (2011) 2.70
VALID: visualization of association study results and linkage disequilibrium. Genet Epidemiol (2009) 2.18
Hierarchical modeling of linkage disequilibrium: genetic structure and spatial relations. Am J Hum Genet (2003) 2.05
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82
Using hierarchical modeling in genetic association studies with multiple markers: application to a case-control study of bladder cancer. Cancer Epidemiol Biomarkers Prev (2004) 1.72
A gene-centric approach to genome-wide association studies. Nat Rev Genet (2006) 1.72
8q24 and prostate cancer: association with advanced disease and meta-analysis. Eur J Hum Genet (2008) 1.72
Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans. PLoS Genet (2011) 1.54
Coverage and power in genomewide association studies. Am J Hum Genet (2006) 1.53
Nonsteroidal antiinflammatory drugs and decreased risk of advanced prostate cancer: modification by lymphotoxin alpha. Am J Epidemiol (2006) 1.53
Impact of meat consumption, preparation, and mutagens on aggressive prostate cancer. PLoS One (2011) 1.52
A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101. Clin Cancer Res (2012) 1.50
Next generation analytic tools for large scale genetic epidemiology studies of complex diseases. Genet Epidemiol (2011) 1.47
Identification, replication, and fine-mapping of Loci associated with adult height in individuals of african ancestry. PLoS Genet (2011) 1.47
Podocalyxin variants and risk of prostate cancer and tumor aggressiveness. Hum Mol Genet (2006) 1.46
Toll-like receptor 4 genetic variation and advanced prostate cancer risk. Cancer Epidemiol Biomarkers Prev (2007) 1.45
Diacylglycerol kinase K variants impact hypospadias in a California study population. J Urol (2012) 1.43
Haplotype tagging single nucleotide polymorphisms and association studies. Hum Hered (2003) 1.29
Socioeconomic status and prostate cancer incidence and mortality rates among the diverse population of California. Cancer Causes Control (2009) 1.28
Dissecting effects of complex mixtures: who's afraid of informative priors? Epidemiology (2007) 1.21
The Covariate's Dilemma. PLoS Genet (2012) 1.19
DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev (2004) 1.19
Turning of COGS moves forward findings for hormonally mediated cancers. Nat Genet (2013) 1.18
Prostatitis, sexually transmitted diseases, and prostate cancer: the California Men's Health Study. PLoS One (2010) 1.16
A genome-wide association study (GWAS) for bronchopulmonary dysplasia. Pediatrics (2013) 1.15
Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk. Clin Cancer Res (2009) 1.13
Prostate cancer aggressiveness locus on chromosome 7q32-q33 identified by linkage and allelic imbalance studies. Neoplasia (2002) 1.11
Role of androgen metabolism genes CYP1B1, PSA/KLK3, and CYP11alpha in prostate cancer risk and aggressiveness. Cancer Epidemiol Biomarkers Prev (2005) 1.09
Relation of serum insulin-like growth factor-I (IGF-I) and IGF binding protein-3 to risk of prostate cancer (United States). Cancer Causes Control (2003) 1.07
Carboxypeptidase 4 gene variants and early-onset intermediate-to-high risk prostate cancer. BMC Cancer (2009) 1.07
Increased power for case-control studies of single nucleotide polymorphisms through incorporation of family history and genetic constraints. Genet Epidemiol (2004) 1.06
Prostate cancer susceptibility variants confer increased risk of disease progression. Cancer Epidemiol Biomarkers Prev (2010) 1.06
Androgen receptor CAG repeats and prostate cancer. Am J Epidemiol (2002) 1.05
The association between a Darc gene polymorphism and clinical outcomes in African American patients with acute lung injury. Chest (2011) 1.02
Association of the innate immunity and inflammation pathway with advanced prostate cancer risk. PLoS One (2012) 1.01
Polymorphisms in polycyclic aromatic hydrocarbon metabolism and conjugation genes, interactions with smoking and prostate cancer risk. Cancer Epidemiol Biomarkers Prev (2006) 0.99
Association of prostate cancer risk and aggressiveness to androgen pathway genes: SRD5A2, CYP17, and the AR. Prostate (2004) 0.98
Copy number alterations in prostate tumors and disease aggressiveness. Genes Chromosomes Cancer (2011) 0.97
A genetic signature of spina bifida risk from pathway-informed comprehensive gene-variant analysis. PLoS One (2011) 0.96
CYP3A4 and CYP3A5 genotypes, haplotypes, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev (2003) 0.96
Generalizability of established prostate cancer risk variants in men of African ancestry. Int J Cancer (2014) 0.96
Novel missense mutations of the Deleted-in-AZoospermia-Like (DAZL) gene in infertile women and men. Reprod Biol Endocrinol (2006) 0.95
The impact of improved microarray coverage and larger sample sizes on future genome-wide association studies. Genet Epidemiol (2013) 0.94
Co-regulatory expression quantitative trait loci mapping: method and application to endometrial cancer. BMC Med Genomics (2011) 0.94
Polymorphisms in estrogen bioactivation, detoxification and oxidative DNA base excision repair genes and prostate cancer risk. Carcinogenesis (2006) 0.94
Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls. Hum Genet (2013) 0.93
Vitamin D receptor genotypes/haplotypes and prostate cancer risk. Cancer Epidemiol Biomarkers Prev (2006) 0.92
Impact of consumption of vegetable, fruit, grain, and high glycemic index foods on aggressive prostate cancer risk. Nutr Cancer (2011) 0.92
Acute lung injury and the coagulation pathway: Potential role of gene polymorphisms in the protein C and fibrinolytic pathways. Intensive Care Med (2006) 0.92
Variants in Deleted in AZoospermia-Like (DAZL) are correlated with reproductive parameters in men and women. Hum Genet (2005) 0.91
Comprehensive evaluation of the association between prostate cancer and genotypes/haplotypes in CYP17A1, CYP3A4, and SRD5A2. Eur J Hum Genet (2004) 0.89
No association between genetic polymorphisms in IGF-I and IGFBP-3 and prostate cancer. Cancer Epidemiol Biomarkers Prev (2004) 0.89
Genetic Analysis Workshop 15: gene expression analysis and approaches to detecting multiple functional loci. BMC Proc (2007) 0.89
Hierarchical modeling in association studies of multiple phenotypes. BMC Genet (2005) 0.89
Prostate cancer aggressiveness locus on chromosome segment 19q12-q13.1 identified by linkage and allelic imbalance studies. Genes Chromosomes Cancer (2003) 0.88
Omega-3 fatty acids, genetic variants in COX-2 and prostate cancer. J Nutrigenet Nutrigenomics (2009) 0.88
Nutrient pathways and neural tube defects: a semi-Bayesian hierarchical analysis. Epidemiology (2009) 0.88
Hypospadias and genes related to genital tubercle and early urethral development. J Urol (2013) 0.85
Genome-wide association studies of cancer. Future Oncol (2007) 0.84
Joint association testing of common and rare genetic variants using hierarchical modeling. Genet Epidemiol (2012) 0.84
MIC1 and IL1RN genetic variation and advanced prostate cancer risk. Cancer Epidemiol Biomarkers Prev (2007) 0.84
Relationship between methylenetetrahydrofolate reductase C677T and A1298C genotypes and haplotypes and prostate cancer risk and aggressiveness. Cancer Epidemiol Biomarkers Prev (2004) 0.83
National Cancer Institute Prostate Cancer Genetics Workshop. Cancer Res (2011) 0.82
Antioxidant and vitamin E transport genes and risk of high-grade prostate cancer and prostate cancer recurrence. Prostate (2013) 0.82
Selenoprotein and antioxidant genes and the risk of high-grade prostate cancer and prostate cancer recurrence. Prostate (2014) 0.82
Trans-fatty acid intake and increased risk of advanced prostate cancer: modification by RNASEL R462Q variant. Carcinogenesis (2007) 0.81
No association between genetic polymorphisms in insulin and insulin receptor substrate-1 and prostate cancer. Cancer Epidemiol Biomarkers Prev (2005) 0.81
Does accounting for gene-environment interactions help uncover association between rare variants and complex diseases? Hum Hered (2013) 0.81
No association between a tetranucleotide repeat polymorphism of CYP19 and prostate cancer. Cancer Epidemiol Biomarkers Prev (2004) 0.80
Copy number variation in bronchopulmonary dysplasia. Am J Med Genet A (2014) 0.79
Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history. Prostate (2007) 0.79
Comparison of missing data approaches in linkage analysis. BMC Genet (2003) 0.79
Maternal smoking, xenobiotic metabolizing enzyme gene variants, and gastroschisis risk. Am J Med Genet A (2014) 0.78
Impact of polymorphisms in drug pathway genes on disease-free survival in adults with acute myeloid leukemia. J Hum Genet (2013) 0.78
Fine-mapping of prostate cancer aggressiveness loci on chromosome 7q22-35. Prostate (2010) 0.78
Population genetic simulations of complex phenotypes with implications for rare variant association tests. Genet Epidemiol (2014) 0.77
Analysis of mutational spectra: locating hotspots and clusters of mutations using recursive segmentation. Stat Med (2002) 0.76
Relationship between body size and prostate cancer in a sibling based case-control study. J Urol (2005) 0.76
Association of testis derived transcript gene variants and prostate cancer risk. J Urol (2007) 0.76
An empirical evaluation of the common disease-common variant hypothesis. BMC Proc (2007) 0.75
Segmentation and estimation for SNP microarrays: a Bayesian multiple change-point approach. Biometrics (2010) 0.75
Host genetic predictors of the kynurenine pathway of tryptophan catabolism among treated HIV-infected Ugandans. AIDS (2016) 0.75
Non-Steroidal Anti-Inflammatory Drugs, Variation in Inflammatory Genes, and Aggressive Prostate Cancer. Pharmaceuticals (Basel) (2010) 0.75
Case-control analyses: Geneopardy! Genet Epidemiol (2005) 0.75
Genome-wide association analyses of expression phenotypes. Genet Epidemiol (2007) 0.75
Update on the State of the Science for Analytical Methods for Gene-Environment Interactions. Am J Epidemiol (2017) 0.75
Of models and methods. Cancer Epidemiol Biomarkers Prev (2011) 0.75
Current Challenges and New Opportunities for Gene-Environment Interaction Studies of Complex Diseases. Am J Epidemiol (2017) 0.75
The role of genetic variation in Toll-like receptor 4 in prostate cancer susceptibility: a review. Expert Opin Med Diagn (2008) 0.75
Parametric linkage analysis. Methods Mol Biol (2002) 0.75
Conference Scene: Lessons learned from the 5th Statistical Analysis Workshop of the Pharmacogenetics Research Network. Pharmacogenomics (2010) 0.75